The Helen Foundation recommends MICRODOSE THERAPYTM as the best for controlling cortisone-responding diseases such as arthritis, asthma, fibromyalgia, multiple sclerosis (MS), osteoarthritis, and Parkinson’s disease.
Cortisone, the medicine used in MICRODOSE THERAPYTM, is the physician’s first choice to bring the chronic inflammation of cortisone-responding diseases under control. Since the body makes extra cortisone when stressed to deal with the stress, cortisone has become known as the stress hormone.
Fear of cortisone side effects causes physicians switch to another medicine for maintenance after achieving control using cortisone. However, no medicine has been able to maintain control satisfactory.
The good news is that a recent scientific discovery allows cortisone (properly hydrocortisone) to also be used for maintenance. The discovery is: sometimes the body loses its ability to make the extra hydrocortisone when stressed. Then inflammation goes out-of-control, and one or more of pain, fatigue, stiffness, breathing problems, movement difficulty, nerve misbehaviour, brain fog, and sleep disturbance sets in. Before this discovery, these symptoms were categorised into separate diseases such as arthritis, asthma, fibromyalgia, multiple sclerosis, osteoarthritis, and Parkinson’s disease. Since these respond to cortisone administration, they are the cortisone-responding diseases. Symptoms vary according to where the inflammation located: asthma if it is in the lungs; osteoarthritis if it is in the joints; Parkinson’s disease if it is in the brain, and so forth.
The solution to cortisone-responding diseases is simple: for maintenance teach patients when, how much and for what reasons to take hydrocortisone to replace the missing hydrocortisone (MICRODOSE THERAPY). Five of six lose symptoms in three weeks. Remission is possible.
When patients are in control of hydrocortisone, they use so little that cortisone side effects do not appear. Cortisone side effects familiar to physicians are due to hydrocortisone over dosing through not knowing how to use cortisone. In proof that MICRODOSE THERAPY solves cortisone side effects, no significant cortisone side effects were observed during the 2,430-participant MICRODOSE THERAPY clinical trial.
The FDA now recommends hydrocortisone be used in accord with the MICRODOSE THERAPY treatment plan for cortisone-responding diseases.
Since hydrocortisone is generic and low cost, there has been no other organization other than the Helen Foundation willing to inform patients about MICRODOSE THERAPY. The Helen Foundation also provides the education program and recommended dosages essential for success of MICRODOSE THERAPY. Dosage must be customized for disease type, disease severity, age, sex, and body weight.